Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000012

Chief Executive Officer returned 9,718 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-15 Returned to the company : show line 1 in the form −9,718 $2.03 $19,706 452,201 D
Loading xslF345X03/edgardoc.xml…